Announcements Trials

Browse Landscape

Phase

Status

Recruiting 2 Active not recruiting 2 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 214 Neoplasms 197 Carcinoma, Non-Small-Cell Lung 91 Colorectal Neoplasms 89 Prostatic Neoplasms 78 Lung Neoplasms 75 Multiple Myeloma 49 Head and Neck Neoplasms 47 Melanoma 46 Pancreatic Neoplasms 45 Neoplasm Metastasis 44 Leukemia, Myeloid, Acute 41 Carcinoma, Hepatocellular 41 Recurrence 37 Brain Neoplasms 37 Squamous Cell Carcinoma of Head and Neck 34 Ovarian Neoplasms 32 Glioblastoma 30 Precursor Cell Lymphoblastic Leukemia-Lymphoma 29 Glioma 29 Uterine Cervical Neoplasms 27 Sarcoma 27 Stomach Neoplasms 26 Lymphoma, Non-Hodgkin 26 Lymphoma 26 Carcinoma, Renal Cell 26 Motor Activity 24 Lymphoma, Follicular 24 Colonic Neoplasms 23 Lymphoma, Large B-Cell, Diffuse 22

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Endometriosis × 90 days × Clear all

NCT04756037 2026-05-13

SERENE

Sumitomo Pharma Switzerland GmbH

Phase 3 Completed

1,164 enrolled 16 charts

Endometriosis, Leiomyoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡